Statistics from Altmetric.com
In this preclinical study, the authors hypothesised that deficiency of protein kinase G-1 (PKG-1), a serine/threonine kinase, would induce pulmonary hypertension (PH) in mice through Rho A/Rho kinase activation.
Protein kinase G-1- knockout (Prkg1−/−) mice had decreased PKG-1 and increased pulmonary artery systolic pressure compared to wild type mice. Prkg1−/− mice had marked microvascular remodelling and precapillary occlusion in the lung, suggesting the two mechanisms cause PH in Prkg1−/− mice. The increased pulmonary artery pressure was independent of left-sided heart disease and systemic hypertension at day 45 in Prkg1−/− mice. Furthermore, the western blot of Prkg1−/− mice showed decreased phosphorylation of Rho A Ser188 and increased activation of Rho A. After fasudil (a Rho kinase inhibitor) treatment, a significant decrease in pulmonary artery pressure was noted in Prkg1−/− mice.
In this study, the authors showed that PKG-1 deficiency results in activation of Rho A-Rho kinase signalling, which causes vascular remodelling and vasoconstriction, leading to PH. Short term inhibition of Rho kinase by fasudil decreased pulmonary pressure in Prkg1−/− mice. Thus, based on the mouse model, PKG-1 deficiency should be one of the important key mechanisms inducing pulmonary artery pressure in Prkg1−/− mice. However, extrapolating this evidence from Prkg1−/− mice to PH human population will require further study.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.